CA
NZ
UK
AU
IND
US
Wednesday, May 13, 2026 will be remembered as one of the most data-dense, headline-saturated trading sessions of the year — a day whenWall Streetwas simultaneously processing a historic inflation shock, a once-in-a-decade presidential summit in Beijing, a looming Federal ReserveLeadershiptransition, and an oil market …
The obesity treatment market has been transformed over the past three years. Semaglutide — marketed as Wegovy for weight management and Ozempic for type 2 diabetes — has become the defining pharmaceutical story of the decade. But Novo Nordisk is not standing still. Data …
There are very few companies in the world about which you can say, with confidence, that civilisation's most important technology cannot function without them. ASML Holding is one of them. The Dutch semiconductor equipment maker occupies a position so singular, so deeply embedded in …
US equities recovered part of their earlier weakness during the final hours of trading, with the S&P 500 ending 0.2% lower, theNasdaqComposite declining 0.7%, and theDow Jones Industrial Averagefinishing nearly unchanged. Investor sentiment remained cautious after stronger-than-expected AprilInflationdata reinforced concerns that elevated energy prices …
Opening Bias & Trading Expectations:Key indicators point to a cautiously optimistic open. U.S. futures were slightly higher overnight, while global risk appetite is supported by strong techEarningsand resilient consumer metrics. Investors will look for catalysts from today’s earnings releases and any fresh news on …
The global biopharmaceutical industry is witnessing one of its most active clinical and regulatory periods in recent memory. May 2026 has delivered a cascade of pivotal Phase 3 data readouts, landmark NDA and sNDA filings, and late-stage clinical milestones that are reshaping treatment landscapes …
On May 13, 2026, Assembly Biosciences (Nasdaq:ASMB) announced that topline Phase 1a clinical data on ABI-6250, its investigational oral hepatitis D virus entry inhibitor, will be presented at the European Association for the Study of the Liver Congress in Barcelona later this month.
KKR's (NYSE:KKR) emergency medical services platform, GMR Solutions, priced its U.S. initial public offering at $15 per share on Tuesday, raising $478.7 million after selling approximately 31.9 million shares. The final pricing came in sharply below the company's initial target range of $22 to …
One of the central anxieties in obesity pharmacotherapy has been what happens when patients stop or switch medications. GLP-1 receptor agonists suppress appetite through biological pathways, and discontinuation has historically produced rapid weight regain. This is not a peripheral concern. With injectable drugs requiring …
Estée Lauder Companies (NYSE:EL) is at a critical inflection point. Once among the most admired luxury consumer names in globalEquitymarkets, the company has spent four years navigating a steep and compounding decline. ItsMarket Capitalisationhas shed over USD 100 billion from its 2021 peak of …
Please wait processing your request...